Indian patent sanctions

India's mass production of generic drugs is not subject to US sanctions, but in China, the situation is different. I think this is actually because the situation in different countries is different. The national conditions of India and China are very different. First of all, the economy, the development of India is far less than that of China. Moreover, some genuine drugs for treating diseases are expensive, and most people can't afford them. Take China, where the economic situation is relatively good, as an example. Only a few rich people can afford expensive genuine drugs, not to mention India, where the economic situation is not so strong. So India has to produce a large number of generic drugs to cure diseases and save lives.

For Americans, human life is precious. So they have always had a good idea that people's lives cannot be used to make money. Saving lives comes first, and profit comes second. The original intention of Indians to produce generic drugs is to cure diseases and save lives, not to make profits. As we all know, the price difference between genuine drugs and generic drugs is very big, but the curative effect is actually similar. So I think this is one of the reasons why the United States can't sanction India.

Indians produce generic drugs to cure diseases and save lives, and the economic strength does not allow most people to buy genuine products. China, on the other hand, is different. Although patients are taking genuine drugs, the current medical subsidies such as minimum living allowance in the country are very perfect, which can help many people solve the treatment problems.

Finally, I think it has been explained in relevant reports that the United States and India have reached an agreement. India can produce generic drugs, but only if it helps the United States to test the efficacy of the drugs produced. I think this is also a kind of mutual understanding.